These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2792662)

  • 41. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
    Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solute-free water retention in preascitic cirrhotic rats following intravenous water loading.
    Sansoe G; Aragno M; Smedile A; Rizzetto M; Rosina F
    J Physiol Pharmacol; 2009 Dec; 60(4):111-7. PubMed ID: 20065504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.
    Ginès P; Jiménez W
    J Hepatol; 1996 Apr; 24(4):506-12. PubMed ID: 8738740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats.
    Tang AH; Ho PM
    Life Sci; 1988; 43(5):399-403. PubMed ID: 3398706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
    Reznick RK; Langer B; Taylor BR; Seif S; Blendis LM
    Gastroenterology; 1983 Apr; 84(4):713-8. PubMed ID: 6337910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of fluid intake on basal and vasopressin-responsive urinary prostaglandin E.
    Campbell HT; Craven PA; DeRubertis FR
    Am J Physiol; 1983 Jul; 245(1):F48-57. PubMed ID: 6869538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum.
    Dolgor B; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Matsumoto T
    J Surg Res; 1998 Oct; 79(2):109-14. PubMed ID: 9758724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolvaptan regulates aquaporin-2 and fecal water in cirrhotic rats with ascites.
    Chen C; Chen RP; Lin HH; Zhang WY; Huang XL; Huang ZM
    World J Gastroenterol; 2016 Mar; 22(12):3363-71. PubMed ID: 27022218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effects of antidiuretic hormone on urinary prostaglandin excretion.
    Fejes-Toth G; Naray-Fejes-Toth A; Frölich JC
    J Pharmacol Exp Ther; 1983 Oct; 227(1):215-9. PubMed ID: 6578322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of DDAVP and AVP on sodium and water balance in conscious rat.
    Gross PA; Anderson RJ
    Am J Physiol; 1982 Nov; 243(5):R512-9. PubMed ID: 7137381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of escape from desmopressin in the rat.
    Gross PA; Kim JK; Anderson RJ
    Circ Res; 1983 Dec; 53(6):794-804. PubMed ID: 6580091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.
    Bosch-Marcè M; Clària J; Titos E; Masferrer JL; Altuna R; Poo JL; Jiménez W; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1999 May; 116(5):1167-75. PubMed ID: 10220509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia.
    Kalambokis GN; Pappas K; Baltayiannis G; Katsanou A; Tsianos EV
    Scand J Gastroenterol; 2010 Dec; 45(12):1509-15. PubMed ID: 20695722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Molecular bases for water/salt retention in experimental liver cirrhosis: aquaporins and renal sodium transporters].
    Fernández-Llama P
    Nefrologia; 2002; 22 Suppl 5():29-33. PubMed ID: 12107914
    [No Abstract]   [Full Text] [Related]  

  • 57. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
    Ishikawa Se ; Saito T; Fukagawa A; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Honda K; Saito T
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1665-71. PubMed ID: 11297601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin-vasopressin interactions on the renal handling of calcium and magnesium.
    Roman RJ; Skelton M; Lechene C
    J Pharmacol Exp Ther; 1984 Aug; 230(2):295-301. PubMed ID: 6589391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
    Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
    Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.